144 related articles for article (PubMed ID: 26173542)
1. Serum testosterone predicts cardiorespiratory fitness impairment in normal-weight women with polycystic ovary syndrome.
Bacchi E; Negri C; Di Sarra D; Tosi F; Tarperi C; Moretta R; Schena F; Bonora E; Kaufman JM; Moghetti P
Clin Endocrinol (Oxf); 2015 Dec; 83(6):895-901. PubMed ID: 26173542
[TBL] [Abstract][Full Text] [Related]
2. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
Harrison CL; Stepto NK; Hutchison SK; Teede HJ
Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
[TBL] [Abstract][Full Text] [Related]
3. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
6. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
7. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
Tosi F; Dorizzi R; Castello R; Maffeis C; Spiazzi G; Zoppini G; Muggeo M; Moghetti P
Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
[TBL] [Abstract][Full Text] [Related]
8. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
10. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
[TBL] [Abstract][Full Text] [Related]
11. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
12. Detailed characterisation of circulatory nitric oxide and free radical indices--is there evidence for abnormal cardiovascular homeostasis in young women with polycystic ovary syndrome?
Willis GR; Udiawar M; Evans WD; Blundell HL; James PE; Rees DA
BJOG; 2014 Dec; 121(13):1596-603. PubMed ID: 24816317
[TBL] [Abstract][Full Text] [Related]
13. Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome.
Rissanen AP; Koskela-Koivisto T; Hägglund H; Koponen AS; Aho JM; Pöyhönen-Alho M; Tiitinen A; Tikkanen HO; Peltonen JE
Physiol Rep; 2016 Feb; 4(4):. PubMed ID: 26884479
[TBL] [Abstract][Full Text] [Related]
14. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.
Echiburú B; Pérez-Bravo F; Maliqueo M; Sánchez F; Crisosto N; Sir-Petermann T
Metabolism; 2008 Dec; 57(12):1765-71. PubMed ID: 19013303
[TBL] [Abstract][Full Text] [Related]
16. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
[TBL] [Abstract][Full Text] [Related]
17. Is muscle mechanical function altered in polycystic ovary syndrome?
Caliskan Guzelce E; Eyupoglu D; Torgutalp S; Aktoz F; Portakal O; Demirel H; Yildiz BO
Arch Gynecol Obstet; 2019 Sep; 300(3):771-776. PubMed ID: 31263987
[TBL] [Abstract][Full Text] [Related]
18. Is cardiorespiratory fitness impaired in PCOS women? A review of the literature.
Donà S; Bacchi E; Moghetti P
J Endocrinol Invest; 2017 May; 40(5):463-469. PubMed ID: 28028784
[TBL] [Abstract][Full Text] [Related]
19. Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome.
Giallauria F; Palomba S; Manguso F; Vitelli A; Maresca L; Tafuri D; Lombardi G; Colao A; Vigorito C; Orio F
Clin Endocrinol (Oxf); 2008 Jan; 68(1):88-93. PubMed ID: 17803701
[TBL] [Abstract][Full Text] [Related]
20. Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism.
Di Sarra D; Tosi F; Bonin C; Fiers T; Kaufman JM; Signori C; Zambotti F; Dall'Alda M; Caruso B; Zanolin ME; Bonora E; Moghetti P
J Clin Endocrinol Metab; 2013 Jun; 98(6):2581-8. PubMed ID: 23596136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]